Results 281 to 290 of about 8,862,620 (337)
Some of the next articles are maybe not open access.
EMERGING ISSUES IN BLOOD SAFETY
Infectious Disease Clinics of North America, 1998Improvements in donor selection, testing of donors for markers of infection, and viral inactivation of plasma-derived products have helped reduce the risk of transfusion-associated infections, including hepatitis B (HBV), hepatitis C (HCV), and human immunodeficiency viruses (HIV). The potential for transmission of emerging infections is illustrated by
M, Chamberland, R F, Khabbaz
openaire +2 more sources
Clinical Orthopaedics and Related Research, 1998
Three of four recipients of transfusion in the United States are patients undergoing surgery, and despite promising advances in the development of alternatives to allogeneic blood transfusion, it is likely that for years to come this patient population will remain dependent on blood donated by volunteers.
openaire +2 more sources
Three of four recipients of transfusion in the United States are patients undergoing surgery, and despite promising advances in the development of alternatives to allogeneic blood transfusion, it is likely that for years to come this patient population will remain dependent on blood donated by volunteers.
openaire +2 more sources
Vaccine, 1998
The safety of blood and blood products is a global issue. Blood transfusion is an important part of modern medicine, but it is also an efficient route of transmission for a number of infectious agents. Although many countries screen all blood donations for a number of infectious agents, a significant proportion of the world's blood supply is either ...
openaire +2 more sources
The safety of blood and blood products is a global issue. Blood transfusion is an important part of modern medicine, but it is also an efficient route of transmission for a number of infectious agents. Although many countries screen all blood donations for a number of infectious agents, a significant proportion of the world's blood supply is either ...
openaire +2 more sources
Journal of Clinical Apheresis, 1993
AbstractThis is a review of events when the medical community realized that AIDS was an infectious disease which might be transmitted by blood transfusions and the response by the various organizations and agencies to curb the potential spread of HIV via blood products.
openaire +2 more sources
AbstractThis is a review of events when the medical community realized that AIDS was an infectious disease which might be transmitted by blood transfusions and the response by the various organizations and agencies to curb the potential spread of HIV via blood products.
openaire +2 more sources
Blood Product Administration Safety
2017For pediatric hematology/oncology and hematopoietic stem cell patients, blood transfusions are a critical component of supportive care. Transfusions have an inherent potential for adverse reactions; however, many of the adverse events or near-miss events are the result of avoidable process errors.
Jennifer Webb, Rahul Shah, Naomi Luban
openaire +1 more source
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly
An overview of real‐world data sources for oncology and considerations for research
Ca-A Cancer Journal for Clinicians, 2022Lynne Penberthy +2 more
exaly
Funding blood safety in the 21st century
Transfusion, 2018Luke Ifland, E. Bloch, J. Pitman
semanticscholar +1 more source